National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$34.00
add to cart

Rights & Permissions

topleft topright

The Infectious Etiology of Chronic Diseases: Defining the Relationship, Enhancing the Research, and Mitigating the Effects -- Workshop Summary (2004)
Board on Global Health (BGH)
Institute of Medicine (IOM)

Citation Manager

. "Appendix A: Workshop Agenda." The Infectious Etiology of Chronic Diseases: Defining the Relationship, Enhancing the Research, and Mitigating the Effects -- Workshop Summary. Washington, DC: The National Academies Press, 2004.

Please select a format:

BibTeX EndNote RefMan


Page
191
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


The Infectious Etiology of Chronic Diseases: Defining the Relationship, Enhancing the Research, and Mitigating the Effects - Workshop Summary

1:00

Testing the reliability of the causal relationship: Considering genetic and environmental susceptibility

Mikhail Pletnikov, Johns Hopkins University School of Medicine

1:30

DNA sequence analysis of a stealth-adapted simian cytomegalovirus

W. John Martin, Center for Complex Infectious Diseases

2:00

Development of vaccines to prevent chronic disease

P. Helena Mäkelä, National Public Health Institute, Helsinki, Finland

2:30

Integrating epidemiology, laboratory research, and surveillance

Siobhán O’Connor, Centers for Disease Control and Prevention

3:00

BREAK

Session VI Discussion Panel: The Next Steps for the Healthcare Community

Panel members, Forum members, and the audience will comment on and respond to considerations such as the role of industry and academic research in developing treatments; the implications for the health care and prevention community in detecting and treating these diseases; and the benefits of managing acute infections vs. chronic diseases—the argument for vaccines and antimicrobials.

3:15

Kathryn Carbone, FDA, Center for Biologics Evaluation and Research

Thomas Shinnick, Centers for Disease Control and Prevention

5:00

Closing Remarks / Adjournment

Page
191